Irvine, CA, United States of America

Michael L Opel

USPTO Granted Patents = 5 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michael L Opel: Innovator in Polymicrobial Infection Treatment

Introduction

Michael L Opel is a notable inventor based in Irvine, CA, who has made significant contributions to the field of medical treatment, particularly in the area of polymicrobial infections. With a total of five patents to his name, Opel's work focuses on innovative methods for detecting and treating infections caused by mixed populations of microbes.

Latest Patents

Opel's latest patents include groundbreaking methods for treating polymicrobial infections. These methods involve detecting and treating infections where a mixed population of microbes, such as bacteria, is present in a patient sample without the need for isolating the microbes first. The inventions describe specific polymicrobial infections and outline methods for treating these infections by selecting particular antibiotics or groups of antibiotics based on the composition of the polymicrobial infections.

Career Highlights

Throughout his career, Michael L Opel has demonstrated a commitment to advancing medical science through his innovative approaches. His work at Cap Diagnostics, LLC has positioned him as a key player in the development of effective treatments for complex infections.

Collaborations

Opel collaborates with talented individuals in his field, including David A Baunoch and Miguel F R Penaranda, who contribute to the research and development of his innovative methods.

Conclusion

Michael L Opel's contributions to the treatment of polymicrobial infections highlight his role as a leading inventor in the medical field. His innovative methods and collaborative efforts continue to pave the way for advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…